SCHEMBL8192015

SCHEMBL8192015

C=C(NC)c1cccc(NC(C(=O)O)C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
POLB P06746 1/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
KDM4E B2RXH2 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3045186 0.86 HDAC8 (0.47) NPSR1PDK1PDK2PDK3PDK4
SCHEMBL3045183 0.86 HDAC8 (0.47) NPSR1PDK1PDK2PDK3PDK4
SCHEMBL17082502 0.81 RAB9A (0.46) TDP1NPSR1PDK1PDK2PDK3
SCHEMBL8176078 0.78 SLC7A5 (0.51) NPSR1ALDH1A1NPC1RAB9APOLB
SCHEMBL3054398 0.77 RAB9A (0.61) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL12401982 0.77 MEN1 (0.49) TDP1NPSR1ALDH1A1MEN1KMT2A
SCHEMBL7936084 0.76 HCRTR2 (0.45) TDP1PDK1PDK2PDK3PDK4
SCHEMBL3047727 0.76 HCRTR2 (0.45) TDP1PDK1PDK2PDK3PDK4
SCHEMBL13224065 0.76 MMP2 (0.50) NPSR1ALDH1A1MEN1KMT2ANPC1
SCHEMBL3042876 0.76 MMP2 (0.50) NPSR1ALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2086963-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-09-16 EP disclosed
WO-2008060927-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-22 WO disclosed